MHRA approves Pfizer-BioNTech’s Comirnaty JN.1 vaccine
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has authorised the use of Pfizer-BioNTech’s adapted Comirnaty vaccine to combat…
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has authorised the use of Pfizer-BioNTech’s adapted Comirnaty vaccine to combat…
Since its introduction in January, the BIOSECURE Act has sent shockwaves across the pharmaceutical sector. Although the Act does not…
This issue is driven by several factors, including the high cost of proprietary medications, the increasing use of the internet…
The European Medicines Agency (EMA) has accepted AstraZeneca's marketing authorisation application for sipavibart as Covid-19 pre-exposure prophylaxis (preventive treatment) in…
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended granting marketing authorisation for Pfizer and…
Novavax has submitted a type II variation application with the European Medicines Agency (EMA) seeking approval for its updated JN.1…
The pharmaceutical and medical communications industry relies heavily on the use and dissemination of scientific journals, research papers, medical reports,…
Novavax has submitted an application to the US Food and Drug Administration (FDA) seeking approval for an updated JN.1 version of…
Moderna has filed an application with the US Food and Drug Administration (FDA) to review its updated Spikevax formula, designed…
The US Food and Drug Administration’s (FDA) vaccine division recommended the development of an updated Covid-19 vaccine at its 5…